These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38791761)

  • 21. Factors influencing adherence to antiretroviral therapy from the experience of people living with HIV and their healthcare providers in Sierra Leone: a qualitative study.
    Lahai M; Theobald S; Wurie HR; Lakoh S; Erah PO; Samai M; Raven J
    BMC Health Serv Res; 2022 Nov; 22(1):1327. PubMed ID: 36348488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study.
    Haribhai S; Khadka N; Mvududu R; Mashele N; Bekker LG; Gorbach P; Coates TJ; Myer L; Joseph Davey DL
    Int J STD AIDS; 2023 Jul; 34(8):548-556. PubMed ID: 36947792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delivering safer conception services to HIV serodiscordant couples in Kenya: perspectives from healthcare providers and HIV serodiscordant couples.
    Ngure K; Kimemia G; Dew K; Njuguna N; Mugo N; Celum C; Baeten JM; Heffron R
    J Int AIDS Soc; 2017 Mar; 20(Suppl 1):21309. PubMed ID: 28361508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda-A qualitative study.
    Ross J; Ingabire C; Umwiza F; Gasana J; Munyaneza A; Murenzi G; Nsanzimana S; Remera E; Akiyama MJ; Anastos KM; Adedimeji A
    PLoS One; 2021; 16(5):e0251645. PubMed ID: 33984044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from Ethiopia.
    Bezabhe WM; Chalmers L; Bereznicki LR; Peterson GM; Bimirew MA; Kassie DM
    PLoS One; 2014; 9(5):e97353. PubMed ID: 24828585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-exposure prophylaxis use among HIV serodiscordant couples: a qualitative study in Mozambique.
    Sack DE; De Schacht C; Paulo P; Graves E; Emílio AM; Matino A; Fonseca CL; Aboobacar AU; Van Rompaey S; Audet CM
    Glob Health Action; 2021 Jan; 14(1):1940764. PubMed ID: 34229580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of antiretroviral therapy adherence among transgender women in South Africa.
    Van der Merwe LL; Moyo I; Mavhandu-Mudzusi AH
    S Afr Fam Pract (2004); 2024 Apr; 66(1):e1-e8. PubMed ID: 38708751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experiences Using Pre-Exposure Prophylaxis for Safer Conception Among HIV Serodiscordant Heterosexual Couples in the United States.
    Bazzi AR; Leech AA; Biancarelli DL; Sullivan M; Drainoni ML
    AIDS Patient Care STDS; 2017 Aug; 31(8):348-355. PubMed ID: 28719229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
    J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the cultural context of HIV stigma on antiretroviral therapy adherence among people living with HIV/AIDS in southwest Nigeria.
    Okoror TA; Falade CO; Olorunlana A; Walker EM; Okareh OT
    AIDS Patient Care STDS; 2013 Jan; 27(1):55-64. PubMed ID: 23305262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Community perspectives on barriers and challenges to HIV pre-exposure prophylaxis access by men who have sex with men and female sex workers access in Nigeria.
    Emmanuel G; Folayan M; Undelikwe G; Ochonye B; Jayeoba T; Yusuf A; Aiwonodagbon B; Bilali C; Umoh P; Ojemeiri K; Kalaiwo A
    BMC Public Health; 2020 Jan; 20(1):69. PubMed ID: 31941469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Empowerment in pregnancy: ART adherence among women living with HIV in Cape Town, South Africa.
    DiClemente-Bosco K; Weber AZ; Harrison A; Tsawe N; Rini Z; Brittain K; Colvin CJ; Myer L; Pellowski JA
    Soc Sci Med; 2022 Mar; 296():114738. PubMed ID: 35078104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving uptake of prevention of mother-to-child HIV transmission services in Benue State, Nigeria through a faith-based congregational strategy.
    Montandon M; Efuntoye T; Itanyi IU; Onoka CA; Onwuchekwa C; Gwamna J; Schwitters A; Onyenuobi C; Ogidi AG; Swaminathan M; Oko JO; Ijaodola G; Odoh D; Ezeanolue EE
    PLoS One; 2021; 16(12):e0260694. PubMed ID: 34855849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study.
    Chadambuka A; Katirayi L; Muchedzi A; Tumbare E; Musarandega R; Mahomva AI; Woelk G
    BMC Public Health; 2017 Jul; 18(1):57. PubMed ID: 28743251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples.
    Ware NC; Wyatt MA; Haberer JE; Baeten JM; Kintu A; Psaros C; Safren S; Tumwesigye E; Celum CL; Bangsberg DR
    J Acquir Immune Defic Syndr; 2012 Apr; 59(5):463-8. PubMed ID: 22267018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV Pre-Exposure Prophylaxis for Conception Among HIV Serodiscordant Couples in the United States: A Cohort Study.
    Leech AA; Biancarelli D; Aaron E; Miller ES; Coleman JS; Anderson PL; Nkwihoreze H; Condron B; Sullivan M
    AIDS Patient Care STDS; 2020 Jul; 34(7):295-302. PubMed ID: 32639209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barriers and facilitators to the implementation and scale up of differentiated service delivery models for HIV treatment in Africa: a scoping review.
    Belay YA; Yitayal M; Atnafu A; Taye FA
    BMC Health Serv Res; 2022 Nov; 22(1):1431. PubMed ID: 36443853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fertility Intentions, Pregnancy, and Use of PrEP and ART for Safer Conception Among East African HIV Serodiscordant Couples.
    Heffron R; Thomson K; Celum C; Haberer J; Ngure K; Mugo N; Bukusi E; Katabira E; Odoyo J; Bulya N; Asiimwe S; Tindimwebwa E; Baeten JM;
    AIDS Behav; 2018 Jun; 22(6):1758-1765. PubMed ID: 28894986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimism alongside new challenges: using a rehabilitation framework to explore experiences of a qualitative longitudinal cohort of people living with HIV on antiretroviral treatment in Lusaka, Zambia.
    Nixon SA; Bond V; Solomon P; Cameron C; Mwamba C; Hanass-Hancock J; Maimbolwa MC; Menon JA; Simwaba P; Sinyinza R; Siwale M; Tattle S; Yates T
    AIDS Care; 2018 Mar; 30(3):312-317. PubMed ID: 28826230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.